Načítá se...
The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications
BACKGROUND: Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidates that have the highest chance of successfully being adopted in the clinic. Th...
Uloženo v:
| Vydáno v: | Cost Eff Resour Alloc |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006586/ https://ncbi.nlm.nih.gov/pubmed/29946228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-018-0105-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|